| Literature DB >> 27217926 |
Said Mohamed1, Ncir Lamya1, Mansour Hamda2.
Abstract
BACKGROUND: Exhausting physical exercise increases lipid peroxidation and causes important muscle damages. The human body tries to mitigate these adverse effects by mobilizing its antioxidant defenses.Entities:
Keywords: Exhaustion, Malondialdehyde; Inflammation; Lipid Peroxidation; Muscle Damage; Race; Runners
Year: 2016 PMID: 27217926 PMCID: PMC4870825 DOI: 10.5812/asjsm.27902
Source DB: PubMed Journal: Asian J Sports Med ISSN: 2008-000X
Maximal Aerobic Speed (MAS) Reached at the end of an Incremental Event (VAMEVAL Test) and Time Sustained During a Supra-Maximal Exhausting Race (Limited-Time Test) by Sedentary Subjects (SS), Long-Distance Runners (LDR) and Middle-Distance Runners (MDR) [a]
| Group | MAS, km/h-1 | Sustained-Time, s |
|---|---|---|
|
| 12.11 ± 1.80 [ | 115.06 ± 12.50 [ |
|
| 20.60 ± 1.20 | 162.80 ± 11.35 |
|
| 16.25 ± 1.35 [ | 131.60 ± 38.00 |
a Values are presented as mean ± SD.
b differ significantly from LDR.
c differ significantly from MDR.
Hematocrit and Hemoglobin Concentration Before and Immediately After an Incremental Event (VAMEVAL Test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR), and Middle-Distance Runners (MDR) [a]
| Variables | VAMEVAL Test | Limited-Time Test | ||
|---|---|---|---|---|
| Before | After | Before | After | |
|
| ||||
| SS | 39.71 ± 5.7 | 41 ± 4.17 | 40.01 ± 5.3 | 40.7 ± 4.34 |
| LDR | 42.43 ± 1.9 | 45.43 ± 4 [ | 42.8 ± 3.2 | 45.85 ± 4.2 [ |
| MDR | 40.85 ± 3.13 | 41.7 ± 3.14 | 40.79 ± 4.8 | 41.28 ± 3.68 |
|
| ||||
| SS | 14.14 ± 2.19 | 14.57 ± 1.9 | 14.09 ± 2 | 14.14 ± 1.9 |
| LDR | 14.85 ± 1.34 | 15.7 ± 1.6 [ | 14.12 ± 1.09 | 15.7 ± 1.6 [ |
| MDR | 14 ± 1.4 | 14.4 ± 1.2 | 13.92 ± 1.7 | 14 ± 1.4 |
a Values are presented as mean ± SD.
b P < 0.05 compared to baseline.
Muscle-Damage Biomarkers, Total Antioxidant Status (TAS) and Catalase Activity Before and Immediately After an Incremental Event (VAMEVAL test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR), and Middle-Distance Runners (MDR) [a]
| Variables | VAMEVAL Test | Limited-Time Test | ||
|---|---|---|---|---|
| Before | After | Before | After | |
|
| ||||
| SS | 51 ± 16 | 349 ± 106 [ | 73 ± 27 | 359 ± 124 [ |
| LDR | 76 ± 11 | 344 ± 190 [ | 92 ± 31 | 365 ± 145 [ |
| MDR | 58 ± 15 | 346 ± 243 [ | 87 ± 29 | 292 ± 142 [ |
|
| ||||
| SS | 149 ± 14 | 198 ± 16 [ | 153 ± 33 | 169 ± 43 |
| LDR | 154 ± 34 | 182 ± 46 [ | 162 ± 47 | 174 ± 61 |
| MDR | 150 ± 35 | 202 ± 85 [ | 166 ± 45 | 177 ± 57 |
|
| ||||
| SS | 281 ± 59 | 396 ± 82 | 301 ± 61 | 535 ± 98 [ |
| LDR | 363 ± 48 | 382 ± 87 | 378 ± 66 | 501 ± 80 [ |
| MDR | 372 ± 50 | 397 ± 86 | 379 ± 43 | 445 ± 64 [ |
|
| ||||
| SS | 1.42 ± 0.42 | 1.38 ± 0.34 | 1.4 ± 0.61 | 1.29 ± 0.56 |
| LDR | 1.58 ± 0.28 | 1.37 ± 0.93 | 1.52 ± 0.17 | 1.19 ± 0.31 [ |
| MDR | 1.76 ± 0.31 | 1.06 ± 0.27 [ | 1.54 ± 0.82 | 1.62 ± 0.98 |
|
| ||||
| SS | 2.62 ± 0.42 | 2.52 ± 0.33 | 2.53 ± 0.54 | 2.49 ± 0.33 |
| LDR | 2.95 ± 0.44 | 1.98 ± 0.11 [ | 2.75 ± 0.62 | 2.88 ± 0.19 |
| MDR | 2.56 ± 0.18 | 2.45±0.48 | 2.49 ± 0.27 | 1.89 ± 0.08 |
a Values are presented as mean ± SD.
b P < 0.05.
c differ significantly to MDR.
d P < 0.01 compared to baseline.
e Differ significantly to the other event.
f Differ significantly to LDR.
Figure 1.Cytokine IL-6 Concentration Before and Immediately After an Incremental Event (VAMEVAL Test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR) and Middle-Distance Runners (MDR)
Values are presented as mean (SD); *P< 0.05, **P < 0.01 compared to baseline; # differ significantly to LDR; ☼ differ significantly to MDR; ♣ differ significantly to the other event.
Figure 2.TNF-α Concentration Before and Immediately After an Incremental Event (VAMEVAL Test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR) and Middle-Distance Runners (MDR)
Values are presented as mean (SD); *P < 0.05 compared to baseline; # differ significantly to LDR.
Figure 3.MDA Concentration Before and Immediately After an Incremental Event (VAMEVAL test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR) and Middle-Distance Runners (MDR)
Values are presented as mean (SD); *P < 0.05 compared to baseline; # differ significantly to LDR; ♣ differs significantly with the other event.